Medical News

RSS

Study suggests cross-infection with P aeruginosa occurs between CF centers in the UK and Canada

A common transmissible strain of the bacteria Pseudomonas aeruginosa has been identified among cystic fibrosis (CF) patients in Canada, suggesting that cross-infection has occurred widely between CF centers in the United Kingdom and Canada, according to a study in the November 17 issue of JAMA. Infection with this strain among Canadian CF patients has been associated with an increased risk of death or lung transplantation.

17 Nov 2010

FDA partners with CDC to kick off Get Smart about Antibiotics Week

This year, millions of antibiotics will be prescribed. Antibiotics can be used to treat bacterial infections; however, they are commonly over-prescribed. Patients sometimes ask their health care professional to prescribe antibiotic drugs for viral infections, like the common cold, despite the fact that they will not work and may lead to potentially harmful side effects. The misuse of antibiotics has contributed to one of the world's most pressing public health problems today, antibiotic resistance.

17 Nov 2010

Kansas may join health lawsuit; 71 lawmakers from 26 states ask to file brief to support law

Kansas City Star: "If Kansas Gov.-elect Sam Brownback and Attorney General-elect Derek Schmidt have their way, Kansas will soon be among" states participating in a federal lawsuit against implementation of the federal health law. "Although several of the lawsuits have been dismissed, one of the most prominent — filed by the state of Florida on behalf of 20 other states — was recently approved for further review.

17 Nov 2010

Shengtai 2010 first quarter sales revenue increases 49.80% to $34,644,572

Shengtai Pharmaceutical, Inc., a manufacturer and distributor in China of glucose and starch as pharmaceutical raw materials and other starch and glucose products, today reported financial results for the three months ended September 30, 2010.

17 Nov 2010

MRL announces acquisition of world's largest cryo-preserved human cancer tissue bank

Molecular Response (MRL), a privately held molecular diagnostic services company and a leader in the identification of target populations for high value therapeutics, announced today the acquisition of the world's largest cryo-preserved human cancer tissue bank—more than 144,000 specimens procured over 20 years. The company acquired the tumor bank, along with properly de-identified clinical information and validated test procedures, as part of a major acquisition of key assets formerly owned by Oncotech.

17 Nov 2010

Type 2 diabetes market in Mexico to grow to $1.22 billion in 2014: Report

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, forecasts that the type 2 diabetes market in Mexico will grow to $1.22 billion in 2014. Drivers of this growth include increasing prevalent population, expanding medical insurance coverage as well as the launch and use of new drugs in the market.

17 Nov 2010

Elsevier launches new module for scientific community

Elsevier , a world-leading publisher of scientific, technical and medical information products and services, today announced the launch of SciVerse Applications beta, a new module within the SciVerse platform that will empower the scientific community to develop and share customized solutions that advance the search and discovery process through its marketplace and developer network.

17 Nov 2010

Maine has most improved health care quality; Kansas needs more dentists

Maine Public Broadcasting Network News: "Nationwide, Maine is most improved when it comes to health care quality, according to 2009 statistics from the federal Agency for Healthcare Research and Quality. In one year, Maine jumped from 12th place to fourth best in categories ranging from cancer to patient safety, from maternal and child health to long-term care.

17 Nov 2010

JDRF, Amylin collaborate to support metreleptin study for type 1 diabetes

The Juvenile Diabetes Research Foundation (JDRF) and Amylin Pharmaceuticals, Inc. announced today that they entered into a research collaboration agreement to provide financial support for a clinical proof-of-concept study to investigate the effects of metreleptin, an analog of the human hormone leptin, in patients with type 1 diabetes. Researchers at The University of Texas (UT) Southwestern Medical Center will conduct the study.

17 Nov 2010

MedAssets acquires The Broadlane Group

MedAssets, Inc. today announced that it has completed its acquisition of The Broadlane Group. The combination of MedAssets and Broadlane creates the industry's leading, end-to-end financial improvement partner that has saved billions for its healthcare provider customers, including more than $2.8 billion in documented and guaranteed supply chain savings.

17 Nov 2010

Medicare roundup: Payment cuts irk healthcare industry; officials mull new prostate-cancer treatment

Doctors across the United States are taking a wait-and-see approach while Congress decides whether or not to allow a scheduled 23% cut in Medicare reimbursement rates to take effect on Dec. 1.

17 Nov 2010

Researchers explore interplay between pain and anxiety

Disability from chronic pain in adolescents can be exacerbated by high levels of anxiety, according to research reported The Journal of Pain, the peer review publication of the American Pain Society.

17 Nov 2010

Study: EGFR inhibtion may help treat triple negative breast cancer

Scientists believe they may have found a new target for treating triple negative breast cancer - one of the more difficult breast cancers to treat successfully and for which there is no targeted therapy at present.

17 Nov 2010

Swissmedic approves use of plasma components treated with Cerus' INTERCEPT Blood System

Cerus Corporation announced today that the Swiss regulatory body, Swissmedic, has approved the use of plasma components treated with Cerus' INTERCEPT Blood System.

17 Nov 2010

Officials look to 2 states for advice on setting up exchanges; other health overhaul news

Two states Massachusetts and Utah are forerunners in establishing health insurance exchanges, a key part of the health overhaul, and are likely to serve as models for other states, Politico reports.

17 Nov 2010

UMass, PolyMedix receive Phase 2 STTR contract to conduct test on antimicrobial compounds

PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat infectious diseases and acute cardiovascular disorders, and the University of Massachusetts, Amherst (UMass), have received a Phase 2 Small Business Technology Transfer (STTR) contract in the amount of $750,000.

17 Nov 2010

New safety reporting website for electronic health records launched

The Wall Street Journal: An alliance of executives from medical societies and professional liability carriers yesterday launched "EHRevent.org, a new safety reporting system for [electronic health records] EHRs. Doctors and other health-care workers can go online and report problems and mistakes they experience as they ramp up the use of digitized records.

17 Nov 2010

Stratatech receives SBIR grant to develop anti-infective living human skin substitute

Stratatech Corp., a privately-held regenerative medicine company, today announced that it has been awarded a $3.5 million Fast-Track SBIR grant to expand the development of its anti-infective living human skin substitute.

17 Nov 2010

AVEO commences enrollment in Phase 1b combination trial of tivozanib with oral capecitabine in advanced tumors

AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that it has initiated patient enrollment in an open-label, multi-center Phase 1b clinical trial evaluating tivozanib in combination with oral capecitabine (Xeloda®) in patients with certain advanced solid tumors.

17 Nov 2010

Avedro's KXL System for corneal cross-linking granted European CE Mark

Avedro, Inc., sponsor of two completed US FDA multi-center clinical trials for corneal cross-linking, today announced that its KXL™ System for performing accelerated corneal cross-linking (KXL) has received the European Union's CE Mark. The CE Mark certifies that the KXL System has met the EU's health and safety standards and opens the door to immediate commercialization across the European Economic Community and in other countries recognizing the CE Mark.

17 Nov 2010

Medical News

Study suggests cross-infection with P aeruginosa occurs between CF centers in the UK and Canada

FDA partners with CDC to kick off Get Smart about Antibiotics Week

Kansas may join health lawsuit; 71 lawmakers from 26 states ask to file brief to support law

Shengtai 2010 first quarter sales revenue increases 49.80% to $34,644,572

MRL announces acquisition of world's largest cryo-preserved human cancer tissue bank

Type 2 diabetes market in Mexico to grow to $1.22 billion in 2014: Report

Elsevier launches new module for scientific community

Maine has most improved health care quality; Kansas needs more dentists

JDRF, Amylin collaborate to support metreleptin study for type 1 diabetes

MedAssets acquires The Broadlane Group

Medicare roundup: Payment cuts irk healthcare industry; officials mull new prostate-cancer treatment

Researchers explore interplay between pain and anxiety

Study: EGFR inhibtion may help treat triple negative breast cancer

Swissmedic approves use of plasma components treated with Cerus' INTERCEPT Blood System

Officials look to 2 states for advice on setting up exchanges; other health overhaul news

UMass, PolyMedix receive Phase 2 STTR contract to conduct test on antimicrobial compounds

New safety reporting website for electronic health records launched

Stratatech receives SBIR grant to develop anti-infective living human skin substitute

AVEO commences enrollment in Phase 1b combination trial of tivozanib with oral capecitabine in advanced tumors

Avedro's KXL System for corneal cross-linking granted European CE Mark

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News